Rajesh Kumar
Stock Analyst at HSBC
(2.82)
# 1,689
Out of 5,138 analysts
29
Total ratings
52.63%
Success rate
8.39%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Reduce | $144 → $143 | $164.42 | -13.03% | 1 | Dec 10, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $225 → $265 | $214.35 | +23.63% | 5 | Dec 10, 2025 | |
| NVO Novo Nordisk | Downgrades: Hold | n/a | $62.33 | - | 3 | Nov 24, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $235 | $237.68 | -1.13% | 2 | Oct 9, 2025 | |
| LLY Eli Lilly and Company | Upgrades: Hold | $675 → $700 | $1,038.40 | -32.59% | 3 | Aug 27, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $27.41 | +53.23% | 1 | Apr 25, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $618.72 | +8.29% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $235.99 | +18.65% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $331.02 | +38.96% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $31.76 | -59.07% | 1 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $55 → $53 | $55.26 | -4.09% | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Reduce | $97 | $41.83 | +131.89% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $109.00 | +13.76% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $25.65 | +94.93% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $108.83 | +13.02% | 1 | Jul 14, 2023 |
Biogen
Dec 10, 2025
Downgrades: Reduce
Price Target: $144 → $143
Current: $164.42
Upside: -13.03%
AbbVie
Dec 10, 2025
Upgrades: Buy
Price Target: $225 → $265
Current: $214.35
Upside: +23.63%
Novo Nordisk
Nov 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $62.33
Upside: -
IQVIA Holdings
Oct 9, 2025
Upgrades: Buy
Price Target: $195 → $235
Current: $237.68
Upside: -1.13%
Eli Lilly and Company
Aug 27, 2025
Upgrades: Hold
Price Target: $675 → $700
Current: $1,038.40
Upside: -32.59%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $27.41
Upside: +53.23%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $618.72
Upside: +8.29%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $235.99
Upside: +18.65%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $331.02
Upside: +38.96%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $31.76
Upside: -59.07%
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $55.26
Upside: -4.09%
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $41.83
Upside: +131.89%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $109.00
Upside: +13.76%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $25.65
Upside: +94.93%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $108.83
Upside: +13.02%